Leukocytapheresis therapy modulates circulating t cell subsets in patients with ulcerative colitis.
about
The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease.Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.Upregulation of GRAIL is associated with remission of ulcerative colitis.Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis.
P2860
Leukocytapheresis therapy modulates circulating t cell subsets in patients with ulcerative colitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@en
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@nl
type
label
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@en
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@nl
prefLabel
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@en
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@nl
P2093
P2860
P1476
Leukocytapheresis therapy modu ...... ients with ulcerative colitis.
@en
P2093
Akira Andoh
Hirozumi Obata
Keiichi Mitsuyama
Masaya Sasaki
Osamu Inatomi
Tomoyuki Tsujikawa
Yasuyuki Deguchi
Yoshihide Fujiyama
P2860
P304
P356
10.1111/J.1774-9987.2005.00270.X
P577
2005-06-01T00:00:00Z